{"id":"https://openalex.org/W2256254040","doi":null,"title":"Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?","display_name":"Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?","publication_year":2003,"publication_date":"2003-12-01","ids":{"openalex":"https://openalex.org/W2256254040","mag":"2256254040","pmid":"https://pubmed.ncbi.nlm.nih.gov/14660727"},"language":"en","primary_location":{"id":"pmid:14660727","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14660727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043569662","display_name":"Robert M. Sharkey","orcid":"https://orcid.org/0000-0003-1408-0905","observed_orcids":["https://orcid.org/0000-0003-1408-0905"]},"institutions":[{"id":"https://openalex.org/I4210131484","display_name":"Center for Molecular Medicine and Immunology","ror":"https://ror.org/03fhjvs31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M Sharkey","raw_affiliation_strings":["Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA. rmsharkey@gscancer.org","Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA. rmsharkey@gscancer.org","institution_ids":["https://openalex.org/I4210131484"]},{"raw_affiliation_string":"Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA","institution_ids":["https://openalex.org/I4210131484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035648827","display_name":"A. J. Brenner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arnold Brenner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jack Burton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jack Burton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"George Hajjar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Hajjar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086538515","display_name":"Stephen P. Toder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen P Toder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088003622","display_name":"Abass A. Alavi","orcid":"https://orcid.org/0000-0002-2442-7901","observed_orcids":["https://orcid.org/0000-0002-2442-7901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abass Alavi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014041155","display_name":"Alexander Matthies","orcid":"https://orcid.org/0000-0002-2009-5575","observed_orcids":["https://orcid.org/0000-0002-2009-5575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Matthies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025991750","display_name":"Donald Edward Tsai","orcid":"https://orcid.org/0000-0001-7397-5296","observed_orcids":["https://orcid.org/0000-0001-7397-5296"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donald E Tsai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080630441","display_name":"Stephen J. Schuster","orcid":"https://orcid.org/0000-0002-3376-8978","observed_orcids":["https://orcid.org/0000-0002-3376-8978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen J Schuster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029801761","display_name":"Edward Allen Stadtmauer","orcid":"https://orcid.org/0000-0002-3935-6069","observed_orcids":["https://orcid.org/0000-0002-3935-6069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward A Stadtmauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110554446","display_name":"Myron Stefan Czuczman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myron S Czuczman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004299253","display_name":"Dominick M. Lamonica","orcid":"https://orcid.org/0000-0003-3219-1916","observed_orcids":["https://orcid.org/0000-0003-3219-1916"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominick Lamonica","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002836262","display_name":"Fran\u00e7oise Kraeber\u2010Bod\u00e9r\u00e9","orcid":"https://orcid.org/0000-0002-3417-0759","observed_orcids":["https://orcid.org/0000-0002-3417-0759"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fran\u00e7oise Kraeber-Bodere","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111556480","display_name":"Beatrice Mah\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatrice Mahe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111629101","display_name":"Jean\u2010Fran\u00e7ois Chatal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Fran\u00e7ois Chatal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090472587","display_name":"Andr\u00e9 Rogatko","orcid":"https://orcid.org/0000-0001-8935-8890","observed_orcids":["https://orcid.org/0000-0001-8935-8890"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Rogatko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073215258","display_name":"G. Mardirossian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Mardirrosian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M Goldenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.765,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.97643141,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"44","issue":"12","first_page":"2000","last_page":"18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/epratuzumab","display_name":"epratuzumab","score":0.9440000057220459},{"id":"https://openalex.org/keywords/anti-cd22-antibody","display_name":"anti-CD22 antibody","score":0.8569999933242798},{"id":"https://openalex.org/keywords/yttrium-90","display_name":"yttrium-90","score":0.9340000152587891},{"id":"https://openalex.org/keywords/111in","display_name":"indium-111","score":0.890999972820282},{"id":"https://openalex.org/keywords/dota-conjugation","display_name":"DOTA conjugation","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.7110000252723694},{"id":"https://openalex.org/keywords/dosimetry","display_name":"dosimetry","score":0.8299999833106995},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.8330000042915344},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9890000224113464},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.628000020980835},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.8805682063102722},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.7974321842193604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5647040605545044},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.5368028283119202},{"id":"https://openalex.org/C75088862","wikidata":"https://www.wikidata.org/wiki/Q2291081","display_name":"Dosimetry","level":2,"score":0.4549744129180908},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34295523166656494},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.29464370012283325},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2215040922164917},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18404632806777954},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.1468963921070099},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006573","descriptor_name":"Heterocyclic Compounds, 1-Ring","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007204","descriptor_name":"Indium","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007554","descriptor_name":"Isotopes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011874","descriptor_name":"Radiometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011878","descriptor_name":"Radiotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D011879","descriptor_name":"Radiotherapy Dosage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015021","descriptor_name":"Yttrium Radioisotopes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015021","descriptor_name":"Yttrium Radioisotopes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:14660727","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14660727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Clinical Trial"},{"id":"mag:2256254040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14660727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7300000190734863,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4218464018","display_name":"RADIOIMMUNOTHERAPY OF NONHODGKINS LYMPHOMA WITH LL2","funder_award_id":"2r01ca067026-04","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W125344597","https://openalex.org/W206701898","https://openalex.org/W629661748","https://openalex.org/W1523748647","https://openalex.org/W1570727439","https://openalex.org/W1573890015","https://openalex.org/W1857296092","https://openalex.org/W1890365994","https://openalex.org/W1923038941","https://openalex.org/W1931731730","https://openalex.org/W1937564833","https://openalex.org/W1940470585","https://openalex.org/W1957738001","https://openalex.org/W1959625971","https://openalex.org/W1965280443","https://openalex.org/W1965361786","https://openalex.org/W1974370610","https://openalex.org/W2041197793","https://openalex.org/W2044360617","https://openalex.org/W2055765679","https://openalex.org/W2084493022","https://openalex.org/W2110646221","https://openalex.org/W2116049862","https://openalex.org/W2118833600","https://openalex.org/W2124835126","https://openalex.org/W2133644731","https://openalex.org/W2151123287","https://openalex.org/W2154253476","https://openalex.org/W2158122865","https://openalex.org/W2164006259","https://openalex.org/W2256690185","https://openalex.org/W2264086468","https://openalex.org/W2320751441","https://openalex.org/W2525772635"],"related_works":["https://openalex.org/W2601819189","https://openalex.org/W2029683286","https://openalex.org/W7206890543","https://openalex.org/W2254519560","https://openalex.org/W7207141706","https://openalex.org/W2013051417","https://openalex.org/W2007734777","https://openalex.org/W2329724209","https://openalex.org/W1989246891","https://openalex.org/W2099087672"],"abstract_inverted_index":{"UNLABELLED:":[0],"A":[1],"DOTA":[2],"(1,4,7,10-tetraazacyclododecane-N,N',N\",N\"'-tetraacetic":[3],"acid)-conjugated,":[4],"(111)In-":[5],"and":[6,24,29,41,86,159,186,201,214,223,303,323,379,397],"(90)Y-labeled":[7],"humanized":[8],"antibody":[9],"to":[10,21,36,183,220,239,258,267,287,349],"CD22,":[11],"epratuzumab,":[12],"was":[13,35,114,142,351,384],"studied":[14],"in":[15,77,90,103,233,280,300,358,388,402],"patients":[16,78,91,254,279],"with":[17,55,65,101,123,150,179,210,274,290,332,338],"non-Hodgkin's":[18],"lymphoma":[19],"(NHL)":[20],"assess":[22],"biodistribution":[23],"tumor":[25,42,321,324,327,340,394],"targeting,":[26],"pharmacokinetics,":[27],"dosimetry,":[28],"anti-antibody":[30,347],"response.":[31],"Of":[32],"particular":[33],"interest":[34],"evaluate":[37],"whether":[38],"pretherapy":[39,52],"targeting":[40,322,398],"dosimetry":[43],"could":[44],"predict":[45],"therapeutic":[46],"responses.":[47],"METHODS:":[48],"Patients":[49],"received":[50],"a":[51,69,96,246,371],"imaging":[53],"study":[54],"(111)In-DOTA-epratuzumab":[56,140],"IgG":[57],"(0.75":[58],"mg/kg),":[59],"followed":[60],"about":[61],"1":[62,282],"wk":[63],"later":[64],"(90)Y-DOTA-epratuzumab":[66,129,137,271],"starting":[67],"at":[68,87],"dose":[70,335,396],"level":[71],"of":[72,156,161,173,265,270,285,313,320,361,377,405],"0.185":[73],"GBq/m(2)":[74,89,269,289],"(5":[75],"mCi/m(2))":[76],"who":[79,92],"had":[80],"prior":[81,97],"high-dose":[82],"chemotherapy":[83],"(group":[84,99],"2),":[85],"0.370":[88,268],"did":[93,329],"not":[94,330],"have":[95],"transplant":[98],"1),":[100],"escalation":[102],"0.185-GBq/m(2)":[104],"increments.":[105],"RESULTS:":[106],"The":[107,133,306],"effective":[108],"blood":[109],"half-life":[110,135],"for":[111,128,136,245,293,374],"(111)In-DOTA":[112],"epratuzumab":[113,350],"36.1":[115],"+/-":[116,125,144,190,196,203,212,216],"7.9":[117],"h":[118,127,146],"(n":[119,130,147,168,192,198,206,229],"=":[120,131,148,169,193,199,207,230],"25)":[121],"compared":[122],"35.2":[124],"7.0":[126],"22).":[132],"whole-body":[134,222],"estimated":[138],"from":[139,237],"scintigraphy":[141],"58.3":[143],"4.7":[145],"20),":[149],"urine":[151],"collection":[152],"confirming":[153],"the":[154,162,221,291,333,339,375,403],"loss":[155],"between":[157],"2.2%":[158],"15.9%":[160],"injected":[163],"activity":[164],"over":[165],"3":[166],"d":[167],"3).":[170],"One-hundred":[171],"sixteen":[172],"165":[174],"CT-confirmed":[175],"lesions":[176,232],"were":[177,255,272,298],"visualized":[178,342],"(111)In-DOTA-epratuzumab.":[180],"Radiation-absorbed":[181],"doses":[182,228,264,284],"liver,":[184],"lungs,":[185],"kidneys":[187],"averaged":[188],"0.55":[189],"0.13":[191],"17),":[194,200],"0.28":[195],"0.06":[197],"0.38":[202],"0.07":[204],"mGy/MBq":[205,218,244],"10),":[208],"respectively,":[209],"0.14":[211],"0.02":[213],"0.23":[215],"0.04":[217],"delivered":[219,336],"red":[224],"marrow,":[225],"respectively.":[226],"Tumor":[227],"14":[231],"10":[234],"patients)":[235],"ranged":[236],"1.0":[238],"as":[240,242],"much":[241],"83":[243],"0.5-g":[247],"lesion":[248],"(median,":[249],"7.15":[250],"mGy/MBq).":[251],"Group":[252],"2":[253,360],"more":[256],"likely":[257],"experience":[259],"significant":[260],"hematologic":[261],"toxicities,":[262],"but":[263],"up":[266,286],"tolerated":[273,283],"standard":[275],"support":[276],"measures,":[277],"whereas":[278],"group":[281],"0.740":[288],"potential":[292],"further":[294,381],"escalation.":[295],"Anti-tumor":[296],"effects":[297],"seen":[299],"both":[301],"indolent":[302],"aggressive":[304],"NHL.":[305],"data":[307],"also":[308],"suggest":[309,367],"that":[310,368,387],"anti-tumor":[311],"responses":[312],"potentially":[314],"equal":[315],"magnitude":[316],"can":[317],"occur":[318],"irrespective":[319],"size.":[325],"Hence,":[326],"response":[328,348],"correlate":[331],"radiation":[334,395],"or":[337],"being":[341],"by":[343,353],"external":[344],"imaging.":[345],"An":[346],"detected":[352],"an":[354],"enzyme-linked":[355],"immunosorbent":[356],"assay":[357],"only":[359],"16":[362],"patients.":[363],"CONCLUSION:":[364],"These":[365],"results":[366],"(90)Y-DOTA-epratuzmab":[369],"is":[370],"promising":[372],"agent":[373],"treatment":[376],"NHL":[378],"warrants":[380],"study.":[382],"There":[383],"evidence":[385],"suggesting":[386],"this":[389],"system,":[390],"factors":[391],"other":[392],"than":[393],"may":[399],"be":[400],"involved":[401],"success":[404],"radioimmunotherapy.":[406]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}